• Mumbai, India
  • Open 24 x 7

Dr. Ajit Pai

Dr. Ajit Pai

MBBS | MS - General Surgery | MCh - Surgical Oncology
  • Skills :
    Senior Surgical Oncologist
highlights

Highlights

  • Dr. Ajit Pai, a highly skilled surgical oncologist based in Chennai, specializes in diagnosing and developing treatment plans for a wide range of cancers, including breast, lung, head and neck, gynecological, prostate, and Ewing’s sarcoma.
  • Dr. Ajit Pai proficiency extends to the effective administration of chemotherapy for the treatment of malignant tumors.
  • In the realm of cancer diagnoses and treatment, seeking the expertise of a specialist like Dr. Pai is essential, surpassing the consultation with a general physician.
profile summary

Profile Summary

Dr. Pai employs advanced diagnostic techniques, such as ultrasound-guided cytology, ensuring precise and accurate diagnoses.

Notably, he has successfully identified and treated uncommon forms of cancer, including giant cell tumors.

Dr. Ajit Pai excels in managing intricate conditions while offering personalized care to his patients. Collaborating with a team of experts, he tailors treatment plans to meet the unique needs of each patient.

Driven by the belief that early detection is paramount in cancer care, he actively encourages patients to undergo preventive cancer screenings, a practice that has proven to save numerous lives.

doctor experience

Experience of Dr. Ajit Pai

He has 18 experience in this field.

trainng and certification

Training and Certifications

  • MBBS
  • MS
  • MCH
  • FRCS(ENGLAND)
  • FACS
expertise

Expertise is Disease/ Treatment

awards and achievements

Awards and Achievements

  • Advanced training: 1. Fellowship training in Liver, gall bladder and biliary cancer surgery from Nagoya, Kyoto and Tokyo Universities
  • Fellowship training in esophageal cancer surgery from Osaka university school of medicine
  • UICC fellowship in Pancreatic cancer surgery from University of Heidelberg, Germany
  • Laparoscopic and Robotic surgery for stomach, esophageal, colon and rectal cancers and for pancreatic and uterine cancers